Dr. Eva Medvedova, MD

  • Portland, OR
  • Hematology (internal medicine) physician
NPI1831242718PAC ID6305034950
Medicare services, 2024
1,170
Medicare patients, 2024
236
Part D claims, 2024
1,320
Publications
21
Clinical trials
5
Practice address
3181 SW Sam Jackson Park Road, Portland, OR 97239
Practice phone
Call (503) 494-9000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

OHSU Hospital

Hospital · Portland, Oregon

See all 7 affiliations

Find Dr. Medvedova's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Eva Medvedova is a hematology (internal medicine) physician in Portland, Oregon

Dr. Medvedova practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Medvedova's NPI, 1831242718, was assigned on January 22, 2007. Dr. Medvedova holds Oregon license MD163041.

NPI and contact details
Medicare PAC ID
6305034950
NPI enumeration date
January 22, 2007
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(503) 494-9000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Eva Medvedova practices at OHSU Hospital in Portland, Oregon

Dr. Medvedova's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

  • OHSU Hospital
    3181 SW Sam Jackson Park Road, Portland, OR 97239 · Multnomah CountyPhone(503) 494-9000

Source: Dmand AI Affiliation Data

Dr. Eva Medvedova is affiliated with 6 sites of care and 1 medical group

Dr. Medvedova's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Medvedova is also affiliated with Adventist Health Portland. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Medvedova to 3 more hospitals and 1 clinical lab, each named with a free account.

See all 7 affiliations for Dr. Medvedova

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Eva Medvedova's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medvedova practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
OHSU HospitalAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Medvedova practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across State of Oregon and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Eva Medvedova is one of 24 hematology (internal medicine) physicians in Oregon

Internal medicine is Dr. Medvedova's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Medvedova's licenses on file in 2 states: Oregon and Massachusetts.

Specialties and state licenses

  • Hematology (internal medicine), OregonPrimaryLicense MD163041 · taxonomy 207RH0000X
  • Internal medicine, MassachusettsLicense 238973 · taxonomy 207R00000X

Hematology (internal medicine) physicians near Dr. Medvedova

Counts of hematology (internal medicine) physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Eva Medvedova billed Medicare for 1,170 services in 2024

CMS data shows 1,170 Medicare services from Dr. Medvedova across 8 procedure codes in 2024, for 236 Medicare patients. Medicare paid $77,781 for them.

Medicare services, 20241,170
Medicare patients236
Paid by Medicare$77,781
Procedure codes8

Dr. Medvedova's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7392024: 7735%
Other services
2023: 02024: 397

Where Dr. Medvedova's Medicare services took place, 2024

  • In an office16814%
  • In a facility1,00286%

Dr. Medvedova compared with the Oregon median for hematology (internal medicine) physicians, 2024

  • Dr. Medvedova
  • Oregon median
Medicare services
1,170vs 4752.5 times
Medicare patients
236vs 13180% above
Part D claims
1,122vs 4442.5 times

Medians across 22 hematology (internal medicine) physicians in Oregon with Dmand AI profiles that report each measure.

Dr. Medvedova's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Medvedova

Need commercial claims for Dr. Medvedova?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Medvedova and other hematology (internal medicine) physicians in Oregon.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Eva Medvedova treated 236 Medicare patients in 2024, average age 71

CMS counts 236 Medicare patients who saw Dr. Medvedova in 2024. The largest group is 65 to 74, with 130 patients. 65% of them have high blood pressure, and 59% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Medvedova's median patient age at 72, with 50% women.

Medicare patients, 2024236
Average age71
Average risk score2.54
Also on Medicaid12%

Dr. Medvedova's Medicare patients by age, 2024

Dr. Medvedova's Medicare patients by sex, 2024

  • Women11549%
  • Men12151%

Chronic conditions among Dr. Medvedova's Medicare patients, 2024

  1. High blood pressure65%
  2. High cholesterol59%
  3. Arthritis36%
  4. Chronic kidney disease33%
  5. Heart failure30%
  6. Mood disorders26%
  7. Atrial fibrillation25%
  8. Depression24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Medvedova's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 72

Patient panel by sex, all payers

  • Women50%
  • Men50%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Eva Medvedova wrote 1,320 Medicare Part D claims in 2024

In 2024, Dr. Medvedova wrote 1,320 Medicare Part D claims for 133 patients. 79% of them were for generic drugs. CMS names the drug for 1,122 of them, across 28 drugs with 11 or more claims each, at $6,812,052 in total drug cost. In 2023, CMS named 944 claims across 28 drugs.

Part D claims, 20241,320
Drugs named by CMS28
Total drug cost$6.8M
Part D patients133

Dr. Medvedova's Part D claims by kind of drug, 2024

  • Generic1,039 claims79%
  • Brand-name281 claims21%

Dr. Medvedova's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Medvedova's Part D claims, 2024

  • Opioids5%66 of 1,320 claims
  • Antibiotics5%61 of 1,320 claims
  • Antipsychotics, patients 65 and over2%24 of 1,320 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 9442024: 1,12219%

Drugs named by CMS: 28 in 2024, 28 in 2023.

See all prescribing by Dr. Medvedova

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Eva Medvedova scored 99 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Medvedova for performance year 2024, reported through an alternative payment model (APM). Dr. Medvedova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Medvedova as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Medvedova's MIPS scores, performance year 2024

  • 99of 100Final score
  • 84.3of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematology (internal medicine) physicians like Dr. Medvedova by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Eva Medvedova has 21 publications on record

Dmand AI links 21 papers to Dr. Medvedova, published from 2011 to 2025. 2022 was the busiest year, with 4. The most frequent topics are Multiple Myeloma, Antineoplastic Combined Chemotherapy Protocols and Dexamethasone. Dr. Medvedova has published most often in Clin Lymphoma Myeloma Leuk. Dr. Medvedova's most frequent co-authors are Rebecca Wang Silbermann, MD, Susan Bal and Natalie S. Callander, MD.

Papers21
Years published2011 to 2025

Dr. Medvedova's papers by year, 2011 to 2025

Topics Dr. Medvedova writes about most

  • Multiple Myeloma
  • Antineoplastic Combined Chemotherapy Protocols
  • Dexamethasone
  • Bortezomib
  • Lenalidomide
  • Antibodies, Monoclonal
  • Transplantation, Autologous
  • Antineoplastic Agents

Dr. Medvedova's most frequent co-authors

Recent publications by Dr. Medvedova

See all 21 publications and co-authors

See who Dr. Medvedova researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Medvedova works with, so you can find a warm path to the right hematology (internal medicine) physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Eva Medvedova has worked on 5 clinical trials

Dmand AI links Dr. Medvedova to 5 clinical trials, 2 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Multiple Myeloma, Blood Protein Disorders and Macroglossia. ECOG-ACRIN Cancer Research Group sponsors the most, 2.

Clinical trials with Dr. Medvedova by phase

  1. 1Phase 1: 1 trial
  2. 2Phase 2: 2 trials
  3. 2Phase 3: 2 trials
  4. NonePhase 4: no trials

Conditions in Dr. Medvedova's trials

  • Multiple Myeloma
  • Blood Protein Disorders
  • Macroglossia
  • Smoldering Multiple Myeloma
  • Hepatomegaly

Investigators on the most trials with Dr. Medvedova

Recent clinical trials with Dr. Medvedova

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Eva Medvedova received $4,732 in industry payments from 2018 to 2025

CMS Open Payments shows 35 general payments to Dr. Medvedova from 2 drug and device companies from 2018 to 2025. Travel and lodging make up the largest share, 74% of the total. Janssen Research & Development, LLC paid the most, $4,580.

General payments to Dr. Medvedova by program year, 2018 to 2025

General payments to Dr. Medvedova by kind, 2018 to 2025

$4.7Kin total
  • Travel and lodging$3,51274%
  • Food and beverage$1,22126%

Companies that paid Dr. Medvedova the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Medvedova

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Eva Medvedova's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Eva Medvedova

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Eva Medvedova's NPI number?

Dr. Eva Medvedova's NPI number is 1831242718. It was assigned on January 22, 2007, and it is active in the NPI Registry.

What kind of doctor is Dr. Eva Medvedova?

Dr. Eva Medvedova is a hematology (internal medicine) physician in Portland, Oregon. The primary specialty in the NPI Registry is Hematology (Internal Medicine) Physician (taxonomy code 207RH0000X).

Where does Dr. Eva Medvedova practice?

Dr. Medvedova practices at 3181 SW Sam Jackson Park Road, Portland, OR 97239. Dr. Medvedova's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dmand AI also links Dr. Medvedova to 3 hospitals and 1 clinical lab.

What is Dr. Eva Medvedova's office phone number?

The practice phone on file for Dr. Medvedova is (503) 494-9000.

What is Dr. Eva Medvedova's medical license number?

Dr. Medvedova holds Oregon license MD163041, one of the licenses on file in 2 states.

Which states has Dr. Eva Medvedova been licensed in?

Dmand AI has state licenses on file for Dr. Medvedova in Oregon and Massachusetts.

Which hospitals is Dr. Eva Medvedova affiliated with?

Dr. Medvedova practices at OHSU Hospital in Portland, Oregon. Dr. Medvedova is also affiliated with Adventist Health Portland. Dmand AI links Dr. Medvedova to 3 more hospitals.

What medical group is Dr. Eva Medvedova part of?

Dr. Medvedova is linked to Oregon Health & Science University (OHSU).

Does Dr. Eva Medvedova accept Medicare?

Yes. CMS data shows Dr. Medvedova billed Medicare for 1,170 services in 2024, and Dr. Medvedova accepts Medicare assignment.

Does Dr. Eva Medvedova offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Medvedova as offering telehealth services.

Show 8 more questionsShow fewer questions

What is Dr. Eva Medvedova's MIPS score?

Dr. Medvedova's MIPS final score for performance year 2024 is 99 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Eva Medvedova see?

CMS counts 236 Medicare patients who saw Dr. Medvedova in 2024, with an average age of 71.

What services does Dr. Eva Medvedova bill to Medicare?

In 2024, Dr. Medvedova's most billed Medicare services were medicare service (G2211), office visit, established patient (99215) and hospital inpatient care (99233).

What drugs does Dr. Eva Medvedova prescribe most?

In 2024 Medicare Part D data, Dr. Medvedova's most prescribed drugs by claims were Acyclovir, Lenalidomide and Revlimid.

Has Dr. Eva Medvedova received payments from drug or device companies?

CMS Open Payments shows $4,732 in general payments to Dr. Medvedova from 2 companies from 2018 to 2025. The largest total came from Janssen Research & Development, LLC.

How long has Dr. Eva Medvedova been practicing?

Dr. Medvedova graduated from medical school in 2002, 24 years ago.

Does Dr. Eva Medvedova do research?

Dmand AI links 21 publications to Dr. Medvedova, published from 2011 to 2025. Dr. Medvedova has worked on 5 clinical trials.

Who does Dr. Eva Medvedova publish with?

Dr. Medvedova's most frequent co-authors are Rebecca Wang Silbermann, MD (10 shared papers), Susan Bal (8 shared papers) and Natalie S. Callander, MD (8 shared papers).

Selling to internal medicine practices?

See hematology (internal medicine) physicians in Oregon by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)